Quarterly report pursuant to Section 13 or 15(d)

Condensed Financial Statements (Details)

v3.10.0.1
Condensed Financial Statements (Details) - USD ($)
 3 Months Ended 6 Months Ended
May 31, 2018
May 31, 2017
May 31, 2018
May 31, 2017
Nov. 30, 2017
Dec. 07, 2016
Nov. 30, 2016
Prior Period Restatement Condensed Financial Statements 41     $ 0        
Secured convertible debentures, net of deferred financing costs $ 943,261   943,261   $ 892,176    
Derivative Liability 596,635   596,635   539,860 $ 285,612  
Total Liabilities 1,825,763   1,825,763   1,865,734    
Accumulated deficit (31,938,885)   (31,938,885)   (31,098,864)    
Total Stockholders' Deficiency (317,569) $ (1,491,136) (317,569) $ (1,491,136) $ 326,623   $ (993,592)
Selling, general and administration 415,425 525,696 705,868 1,004,856      
Total Operating Expenses 399,204 518,213 701,027 1,023,167      
Loss from Operations (358,934) (473,214) (653,382) (958,846)      
Change in fair value of derivative liabilities (62,740) 24,052 (61,349) 595,700      
Accretion 29,363 86,609 58,111 155,271      
Loss before Income Taxes (484,309) (681,588) (840,021) (821,556)      
Net loss for the period (484,309) (681,588) (840,021) (821,556)      
Comprehensive Loss $ (485,988) $ (681,945) $ (842,274) $ (799,760)      
Loss per share - basic and diluted $ (0.005) $ (0.012) $ (0.009) $ (0.014)      
Foreign currency translation (gain) loss     $ 11,600 $ 6,811      
Net cash used in operating activities     $ (884,132) (1,031,024)      
Prior to Restatement [Member]              
Secured convertible debentures, net of deferred financing costs   $ 1,669,359   1,669,359      
Derivative Liability   381,671   381,671      
Total Liabilities   2,445,674   2,445,674      
Accumulated deficit   29,159,079   29,159,079      
Total Stockholders' Deficiency   1,530,046   1,530,046      
Foreign currency translation (gain)   20,445   7,289      
Selling, general and administration   587,581   1,111,194      
Total Operating Expenses   580,286   1,129,027      
Loss from Operations   535,287   1,064,706      
Change in fair value of derivative liabilities   86,000   507,379      
Accretion   0   106,338      
Loss before Income Taxes   595,104   860,466      
Net loss for the period   595,104   860,466      
Comprehensive Loss   $ 595,461   $ 838,670      
Loss per share - basic and diluted   $ (0.010)   $ (0.020)      
Net Loss       $ 860,466      
Foreign currency translation (gain) loss       7,289      
Net cash used in operating activities       1,031,024      
Restated [Member]              
Secured convertible debentures, net of deferred financing costs   $ 1,433,593   1,433,593      
Derivative Liability   579,775   579,775      
Total Liabilities   2,408,012   2,408,012      
Accumulated deficit   29,120,169   29,120,169      
Total Stockholders' Deficiency   1,491,136   1,491,136      
Foreign currency translation (gain)   20,633   6,811      
Selling, general and administration   525,696   1,004,856      
Total Operating Expenses   518,213   1,023,167      
Loss from Operations   473,214   958,846      
Change in fair value of derivative liabilities   24,052   595,700      
Accretion   86,609   155,271      
Loss before Income Taxes   681,588   821,556      
Net loss for the period   681,588   821,556      
Comprehensive Loss   $ 681,945   $ 799,760      
Loss per share - basic and diluted   $ (0.012)   $ (0.014)      
Net Loss       $ 821,556      
Foreign currency translation (gain) loss       6,811      
Net cash used in operating activities       $ 1,031,024